Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms-Reference-Cited by-同舟云学术

Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms

Published:2018-02-15 Issue:24 Volume:9 Page:16932-16950
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Baum Richard P.¹,Kulkarni Harshad R.¹,Singh Aviral¹,Kaemmerer Daniel²,Mueller Dirk¹,Prasad Vikas³,Hommann Merten²,Robiller Franz C.⁴,Niepsch Karin¹,Franz Holger⁵,Jochems Arthur⁶,Lambin Philippe⁶⁷,Hörsch Dieter⁸

Affiliation:

1. THERANOSTICS Center for Molecular Radiotherapy, Zentralklinik Bad Berka GmbH, Bad Berka, Germany

2. Department of General and Visceral Surgery, Zentralklinik Bad Berka GmbH, Bad Berka, Germany

3. Clinic for Nuclear Medicine, Charité, Berlin, Germany

4. Center of Molecular Imaging, Zentralklinik Bad Berka GmbH, Bad Berka, Germany

5. Lohmann and Birkner, Berlin, Germany

6. Department of Radiology, GROW - School for Oncology and Developmental Biology, Maastricht University Hospital, Maastricht, The Netherlands

7. Department of Radiation Oncology (The D-Lab), GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands

8. Department of Gastroenterology/Endocrinology, Center for Neuroendocrine Tumors Bad Berka - ENETS Center of Excellence, Zentralklinik Bad Berka GmbH, Bad Berka, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequencing of Somatostatin-Receptor–Based Therapies in Neuroendocrine Tumor Patients;Journal of Nuclear Medicine;2024-01-18

2. Surgery in Combination with Peptide Receptor Radionuclide Therapy: A Novel Approach for the Treatment of Advanced Neuroendocrine Tumours;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024

3. From Radioimmunodetection to Radiomolecular Precision Oncology Via Radionanotargeting by Intelligent Multidisciplinary Radiotheragnostic Nanoparticles;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024

4. ペプチド受容体放射性リガンドを用いた膵NENの診断と治療;Suizo;2023-12-28

5. Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group;Advances in Therapy;2023-11-21